Analyzing Cellebrite DI (NASDAQ:CLBT) & Riskified (NYSE:RSKD)

Riskified (NYSE:RSKDGet Free Report) and Cellebrite DI (NASDAQ:CLBTGet Free Report) are both technology companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, earnings, dividends, valuation, risk and institutional ownership.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for Riskified and Cellebrite DI, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Riskified 2 3 2 0 2.00
Cellebrite DI 1 0 5 0 2.67

Riskified presently has a consensus target price of $6.50, suggesting a potential upside of 9.34%. Cellebrite DI has a consensus target price of $16.70, suggesting a potential upside of 46.11%. Given Cellebrite DI’s stronger consensus rating and higher probable upside, analysts clearly believe Cellebrite DI is more favorable than Riskified.

Profitability

This table compares Riskified and Cellebrite DI’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Riskified -4.23% -3.93% -2.79%
Cellebrite DI 11.43% 15.58% 8.29%

Institutional and Insider Ownership

59.0% of Riskified shares are held by institutional investors. Comparatively, 45.9% of Cellebrite DI shares are held by institutional investors. 17.4% of Riskified shares are held by insiders. Comparatively, 5.7% of Cellebrite DI shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Earnings and Valuation

This table compares Riskified and Cellebrite DI”s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Riskified $344.64 million 2.56 -$27.57 million ($0.11) -54.05
Cellebrite DI $475.67 million 5.99 $78.33 million $0.22 51.95

Cellebrite DI has higher revenue and earnings than Riskified. Riskified is trading at a lower price-to-earnings ratio than Cellebrite DI, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

Riskified has a beta of 1.38, indicating that its share price is 38% more volatile than the S&P 500. Comparatively, Cellebrite DI has a beta of 1.15, indicating that its share price is 15% more volatile than the S&P 500.

Summary

Cellebrite DI beats Riskified on 11 of the 14 factors compared between the two stocks.

About Riskified

(Get Free Report)

Riskified Ltd., together with its subsidiaries, develops and offers an e-commerce risk management platform that allows online merchants to create trusted relationships with consumers in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and the Americas. It offers Chargeback Guarantee that ensures the legitimacy of merchants' online orders; Policy Protect, a machine learning solution designed to detect and prevent refund and returns policy abuse in real-time; Account Secure, a solution that cross-checks every login attempt; Dispute Resolve, which is used to compile submissions for fraud and non-fraud related chargeback issues; and PSD2 Optimize that helps merchants avoid bank authorization failures and abandoned shopping carts. The company serves direct-to-consumer brands, online-only retailers, omnichannel retailers, online marketplaces, and e-commerce service providers in various industries, such as payments, money transfer and crypto, tickets and travel, electronics, home, and fashion and luxury goods. Riskified Ltd. was incorporated in 2012 and is headquartered in Tel Aviv, Israel.

About Cellebrite DI

(Get Free Report)

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft. It provides Inseyets, a digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations. The company's digital forensics software also offers data extraction, decoding capabilities, workflows, and automation capabilities. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence by automating data analysis and visualization; Smart Search, an open source intelligence tool that automates the collection and review of publicly available online data; and Guardian, a case and evidence management solution. Further, the company offers digital forensic software for enterprises and service providers, including Inseyets for Enterprise, Endpoint Inspector, and Mobile Now; and professional services, such as training and certification services, and other services. It serves federal and state and local agencies. The company was incorporated in 1999 and is headquartered in Petah Tikva, Israel.

Receive News & Ratings for Riskified Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Riskified and related companies with MarketBeat.com's FREE daily email newsletter.